Current view and outcome of ITI therapy - A change over time?


HOLSTEIN K., BATOROVA A., CARVALHO M., FIJNVANDRAAT K., HOLME P., Kavakli K. , ...More

THROMBOSIS RESEARCH, vol.148, pp.38-44, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 148
  • Publication Date: 2016
  • Doi Number: 10.1016/j.thromres.2016.10.015
  • Title of Journal : THROMBOSIS RESEARCH
  • Page Numbers: pp.38-44

Abstract

Introduction: Inhibitor development in people with haemophilia is a serious complication that may require intensive and costly interventions. The goal of inhibitor management should be permanent inhibitor eradication through immune tolerance induction (ITI), but well-designed studies are lacking and the management of patients is therefore defined by the experience and views of the clinician.